Ebola Outbreak in DR Congo Potential Impact on Regional Industries and Investment Risk Quantum Computing Progress Nvidia and Microsoft Lead the Way Amid Shifting Expert Views Walmart Price Target Lowered by UBS to 141 After Q1 Results SoftBank Group Surges 61 Billion in Market Cap Over Two Days on AI Optimism Japan Core Inflation Slips to Over FourYear Low Dampening Expectations for BOJ Rate Hike Navigating Social Security Claiming Now or Waiting for Survivor Benefits at 67 Eagle Point Credit Company Inc ECC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism AbbVie ABBV Q1 2026 Earnings Slight EPS Beat Amid Steady Performance ZBIO Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside PPTA Q1 2026 Earnings WiderThanExpected Loss Amidst Antimony Project Progress KT Q1 2026 Earnings EPS Miss Weighs on Shares Revenue Details Not Disclosed SCPQW Warrants Hold Steady at 063 as Support and Resistance Levels Tighten MFS Multimarket Income Trust MMT Holds Steady at 449 as Trading Range Narrows Strategy Inc MSTR Holds Steady Near 153 as Market Awaits Catalyst LaFayette Acquisition Corp Rights LAFAR Holds Steady at 012 Trading Range Narrows Lake Shore Bancorp LSBK Holds Steady at 1560 as Consolidation Narrows Steel Stocks Surge as Government Extends Minimum Import Price on 66 Steel Products CompX International Inc CIX Q1 2026 Earnings Solid EPS Performance Amid Market Uncertainty Encompass Health EHC Consolidates Near Key Level After Modest Decline Redwood Trust Inc RWT Edges Higher Resilience Amid Mortgage Market Volatility Public Service Enterprise Group PEG Shows Modest Uptick Amid Utility Sector Stability Gores Holdings X Inc Warrants GTENW Hold Steady at 065 Key Levels in Focus High Income Securities Fund PCF Holds Steady Near Support Amid Low Volatility GAMCO Global Gold Natural Resources Income Trust GGN Weakness Testing Support Zone as Gold Sector Faces Headwinds Birkenstock BIRK Surges 46 Rebounds from Support Eyes Resistance Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone